Meeting
2016 ASCO Annual Meeting
P53 functional mutation type in high grade serous ovarian cancer and clinical outcomes.
Authors
Victoria Mandilaras
Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada
Victoria Mandilaras , Swati Garg , Julia Burnier , Katherine Karakasis , Lisa Wang , Helen Mackay , Neesha C. Dhani , Marcus O. Butler , Victor Rodriguez-Freixinos , Michelle K. Wilson , Cristina Martin-Lorente , Josee-Lyne Ethier , Philippe L. Bedard , Lillian L. Siu , Blaise Clarke , Patricia Ann Shaw , Tracy Stockley , Amit M. Oza , Stephanie Lheureux
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5550)
DOI
10.1200/JCO.2016.34.15_suppl.5550
Abstract #
5550
Poster Bd #
373
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2016 Gastrointestinal Cancers Symposium
Effect of age and ethnicity on the tumor location, nuclear accumulation of p53 and clinical outcome in colorectal adenocarcinoma.
First Author: Ravi Kumar Paluri
Poster
2024 ASCO Genitourinary Cancers Symposium
Molecular characterization of metastatic penile carcinoma (mPC) in developing countries and its association with clinical outcomes: LACOG 2018 FOUNDATION translational trial.
First Author: Fernando Sabino Marques Monteiro
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
First Author: Daniel Aaron Fox